ArticleCell death & disease2020

Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis.

Feiye Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.